RXRX

NASD Recursion Pharmaceuticals, Inc. Class A

Oct 29, 2026 · 4:16 PM ET LAST TRADE Market Closed

$4.23 ↓ -0.13 (-2.87%) Trading Down from the previous close of $4.35, $0.29 below the day’s high of $4.52

YTD change: +3.30%
vs 20-day SMA: +5.92%
vs 200-day SMA: +19.58%

Price ranges

Previous day

$3.99 $4.43

open $4.00 close $4.35

+$0.35 (+8.75%)

Today

$4.15 $4.52

open $4.24 now $4.23

-$0.02 (-0.35%)

Past week

$3.45 $4.43

from $3.64 now $4.23

+$0.59 (+16.07%)

Past month

$3.44 $5.19

from $4.13 now $4.23

+$0.09 (+2.30%)

This year

$2.77 $5.24

from $4.09 now $4.23

+$0.14 (+3.30%)

Price & Performance

+1.05 (+31.82%) / 6M

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral

The stock is 90.1% away from all-time highs of $42.81
RXRX is up 3% since the beginning of the year
RXRX is down 28% over the past 12 months
RXRX is up 2% over the past 1 month
33% of all RXRX investors are betting against RXRX

RXRX reads neutral: price sits above both the 20- and 200-day averages, the 12-month move is -25.9%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No

EPS $-0.25

Earnings momentum -14.2% Quarterly EPS growth

Quarterly change -14.2%

Valuation

P/E ratio N/A

Enterprise value $1.8B

Beta 2.77

Balance sheet & scale

IncomeN/A

Revenue$54.9M

Cash$551.1M

Debt$66.6K

Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD

Sector Professional, Scientific, and Technical Services

Industry Group Scientific Research and Development Services

Market cap $2.5B

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel medicines. Its Recursion operating system enables advanced machine learning approaches to reveal drug candidates, mechanisms of action, novel chemistry, and potential toxicity, with the eventual goal of decoding biology and advancing new therapeutics that radically improve people's lives. The company was founded by Blake Borgeson, Christopher C. Gibson, and Dean Y. Li on November 4, 2013 and is headquartered in Salt Lake City, UT.

Competitor comparison

Ticker	Company	Price	Change
AMGN	Amgen Inc.	$451.83	+0.87%
MRNA	Moderna, Inc.	$214.17	+2.98%
RVMD	Revolution Medicines, Inc.	$188.72	+1.34%
ROIV	Roivant Sciences Ltd.	$37.11	+1.56%
BNTX	BioNTech SE Sponsored ADR	$87.99	+1.07%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.